Taiwan FDA registration cccbfe205f6845ab847e32af0b5075c1
Mitsubishi antistreptolysin O reagent
TW: 三菱抗鏈球菌溶血素O試劑
Taiwan·Risk Class 1·MITSUBISHI CHEMICAL MEDIENCE CORPORATION YACHIYO AREA·Registered Nov 04, 2005 – Nov 04, 2015CancelledRegistration details
- Analysis ID
- cccbfe205f6845ab847e32af0b5075c1
- Customs Code
- DHA04400173901
Company information
- Manufacturer Country
- Japan
- Authorized Representative
- Jingxiang Co., Ltd
Product details
- Intended Use
- The amount of anti-chain coccal hemolysin "O" in human serum was analyzed.
- Product Type (Level 1)
- C Immunology and microbiology
- Product Type (Level 2)
- C.3720 鏈球菌屬胞外酶試劑
- Import Information
- import
Dates and status
- Registration Date
- Nov 04, 2005
- Expiry Date
- Nov 04, 2015
- Cancellation Date
- Jun 07, 2018
Cancellation information
- Status
- Logged out
- Reason
- 許可證已逾有效期
About this record
Access comprehensive regulatory information for Mitsubishi antistreptolysin O reagent in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 1 medical device is registered under number cccbfe205f6845ab847e32af0b5075c1 and manufactured by MITSUBISHI CHEMICAL MEDIENCE CORPORATION YACHIYO AREA. The authorized representative in Taiwan is Jingxiang Co., Ltd.
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices